Shanghai Sanyou Medical Co. Ltd. (688085) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Sanyou Medical Co. Ltd.

Why is Shanghai Sanyou Medical Co. Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 7.88% and Operating profit at -24.68% over the last 5 years

The company has declared positive results in Mar'2025 after 9 consecutive negative quarters

NET PROFIT(Q) At CNY 12.83 MM has Grown at 544.4%
NET SALES(HY) At CNY 234.69 MM has Grown at 26.44%
RAW MATERIAL COST(Y) Fallen by -44.1% (YoY)

With ROE of 1.92%, it has a expensive valuation with a 2.83 Price to Book Value

Over the past year, while the stock has generated a return of 0.26%, its profits have risen by 33.4% ; the PEG ratio of the company is 4.4

Underperformed the market in the last 1 year

The stock has generated a return of 0.26% in the last 1 year, much lower than market (China Shanghai Composite) returns of 14.77%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shanghai Sanyou Medical Co. Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shanghai Sanyou Medical Co. Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shanghai Sanyou Medical Co. Ltd.

0.26%

-0.05

46.73%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.88%

EBIT Growth (5y)

-24.68%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.19

Sales to Capital Employed (avg)

0.25

Tax Ratio

26.42%

Dividend Payout Ratio

7.58%

Pledged Shares

Institutional Holding

ROCE (avg)

11.81%

ROE (avg)

6.42%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

147

Industry P/E

Price to Book Value

2.83

EV to EBIT

216.60

EV to EBITDA

61.57

EV to Capital Employed

3.68

EV to Sales

10.66

PEG Ratio

4.41

Dividend Yield

0.01%

ROCE (Latest)

1.70%

ROE (Latest)

1.92%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company

NET PROFIT(Q)

At CNY 12.83 MM has Grown at 544.4%

NET SALES(HY)

At CNY 234.69 MM has Grown at 26.44%

RAW MATERIAL COST(Y)

Fallen by -44.1% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 5.77%

PRE-TAX PROFIT(Q)

Highest at CNY 14.39 MM

EPS(Q)

Highest at CNY 0.04

-10What is not working for the Company

INTEREST(9M)

At CNY 0.55 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Lowest at CNY 47.54 MM

ROCE(HY)

Lowest at 1.34%

DEBT-EQUITY RATIO (HY)

Highest at -18.85 %

Here's what is working for Shanghai Sanyou Medical Co. Ltd.

Net Profit

At CNY 12.83 MM has Grown at 544.4%

over average net sales of the previous four periods of CNY 1.99 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Pre-Tax Profit

At CNY 14.39 MM has Grown at 161.41%

over average net sales of the previous four periods of CNY 5.51 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Sales

At CNY 234.69 MM has Grown at 26.44%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 14.39 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 12.83 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.04

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debtors Turnover Ratio

Highest at 5.77%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -44.1% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai Sanyou Medical Co. Ltd.

Interest

At CNY 0.55 MM has Grown at inf%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY 47.54 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debt-Equity Ratio

Highest at -18.85 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio